Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Dr. Anant Vinjamoori is joining as the Chief Medical Officer of the Hims brand. As the company reimagines how everyone can access proactive, comprehensive care that helps them feel great, Dr. Vinjamoori will provide the clinical guidance that shapes the next phase of the Hims brand across sexual health, hormone health, dermatology, weight loss, and mental health, as well as emerging categories like longevity medicine and peptide therapy. He joins a team of medical experts at Hims & Hers led by Global Chief Medical Officer, Dr. Pat Carroll.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260604732825/en/

An expert in longevity medicine and preventive healthcare, Vinjamoori joins Hims & Hers to help more men feel great at every stage of life

Dr. Vinjamoori has more than a decade of clinical and executive experience in internal medicine, primary care, and longevity. He has led both product and medical teams at prominent health technology companies, including Virta Health and Modern Age. He is a leading expert in preventive and longevity care, combining deep clinical experience with command of the latest diagnostic and therapeutic technologies—from advanced diagnostic testing to targeted therapies such as peptides—to support recovery, cognition, sleep, and body composition. As the founder of Next Generation Medicine, he provides best-in-class medical education and AI technology to help clinicians learn, implement, and scale evidence-based, clinically rigorous longevity medicine in their practices. Dr. Vinjamoori has also served as an advisor to consumer wellness companies like Superpower and Midi Health. He is the author of several peer-reviewed publications, and he received his MD from Harvard Medical School and his MBA from Harvard Business School.

“Men are increasingly seeking care that goes beyond reactive treatment – they want to feel their best at every age, and they are paying close attention to the science that makes that possible,” said Dr. Anant Vinjamoori. “This is the right time to increase access to high-quality, science-driven care that helps men feel like the best versions of themselves. Hims has the scale, consumer trust, and vision to do it right. I can’t wait to get started.”

“As medicine advances, we have a responsibility to bring our customers the latest innovations in treatments, services, and research,” said Dr. Pat Carroll, Global Chief Medical Officer of Hims & Hers. “Dr. Vinjamoori has been at the leading edge of helping people feel great at every stage of life, and he brings the perfect combination of clinical expertise and dedication to consumer access to Hims & Hers. I’m excited to see the deep impact he will have on our Hims customers.”

The team of medical leaders at Hims & Hers has more than 100 years of combined experience across weight loss, sexual health, hormone health, mental health, dermatology, and primary care. These physicians are the clinical backbone of the company, providing critical medical expertise that ensures the care available through Hims & Hers is rooted in the latest research and clinical guidelines.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260604732825/en/

The Hims & Hers Health Registered (A) Stock at the time of publication of the news with a fall of -2,11 % to 23,24EUR on Tradegate stock exchange (04. Juni 2026, 14:59 Uhr).

Schreibe Deinen Kommentar